EPIPHANY TECHNOLOGY ACQUISIT - *W EXP 01/12/202 (EPHYW)

CUSIP: 29429X117

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / *W EXP 01/12/202
Total 13F shares
8,576,265
Share change
-277,632
Total reported value
$2,900,000
Price per share
$0.34
Number of holders
41
Value change
-$332,620
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 29429X117?
CUSIP 29429X117 identifies EPHYW - EPIPHANY TECHNOLOGY ACQUISIT - *W EXP 01/12/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EPIPHANY TECHNOLOGY ACQUISIT - *W EXP 01/12/202 (EPHYW) as of Q1 2022

As of 31 Mar 2022, EPIPHANY TECHNOLOGY ACQUISIT - *W EXP 01/12/202 (EPHYW) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,576,265 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, LH Capital Markets, LLC, ARISTEIA CAPITAL LLC, Saba Capital Management, L.P., Linden Advisors LP, Castle Creek Arbitrage, LLC, Polar Asset Management Partners Inc., FIR TREE CAPITAL MANAGEMENT LP, CITADEL ADVISORS LLC, and CANTOR FITZGERALD, L. P.. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.